1. Articles from biospace.com

  2. 1-24 of 186 1 2 3 4 5 6 7 8 »
    1. How Not to Be a Token Board Member: Diversity in Leadership

      How Not to Be a Token Board Member: Diversity in Leadership

      How Not to Be a Token Board Member: Diversity in Leadership Corporate boards are gradually diversifying, but in 2021, only 36% of S&P 500 and Fortune 500 companies had three or more female directors, according to Catalyst. In biotech, the percentage is even lower. In 2020, the Biotechnology Innovation Organization (BIO) reported that only 18% of its members’ directors were female and 14% were people of color...

      Read Full Article
    2. Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors

      Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors

      Rubius Therapeutics Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced the appointment of Susanne Schaffert, Ph.D., to its board of directors...

      Read Full Article
    3. Precision BioSciences Appoints Melinda Brown to Board of Directors

      Precision BioSciences Appoints Melinda Brown to Board of Directors

      Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that Melinda Brown has been appointed as a Director on the Company’s Board of Directors and Chair of the Board’s Audit Committee...

      Read Full Article
    4. Poseida Therapeutics Appoints Charles M. Baum, M.D., Ph.D., to Board of Directors

      Poseida Therapeutics Appoints Charles M. Baum, M.D., Ph.D., to Board of Directors

      Poseida Therapeutics, Inc.  (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced the appointment of Charles M. Baum, M.D., Ph.D., to its Board of Directors...

      Read Full Article
    5. Beta Bionics Appoints Gilad Glick to the Board of Directors and Veena Rao, Ph.D. as Chief Commercial Officer

      Beta Bionics Appoints Gilad Glick to the Board of Directors and Veena Rao, Ph.D. as Chief Commercial Officer

      Beta Bionics, Inc. — a clinical-stage medical technology company committed to the design, development, and commercialization of the iLet® Bionic Pancreas — today announced the appointments of Gilad Glick, former Chief Executive Officer, Itamar Medical, to the Board of Directors and Veena Rao, Ph.D., to the role of Chief Commercial Officer...

      Read Full Article
    6. ChromaDex Appoints Ann Cohen and Kristin Patrick to its Board of Directors

      ChromaDex Appoints Ann Cohen and Kristin Patrick to its Board of Directors

      ChromaDex, Inc. (NASDAQ: CDXC) today announced that it has appointed two new members to its Board of Directors: Kristin Patrick, Executive Vice President and Chief Marketing Officer of Claire's Inc., and Ann Cohen, Executive Vice President and Chief Financial Officer of The Institute of Internal Auditors (The IIA)...

      Read Full Article
    1-24 of 186 1 2 3 4 5 6 7 8 »
  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content